{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:56:07Z","timestamp":1789916167250,"version":"4.0.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:00:00Z","timestamp":1734566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:00:00Z","timestamp":1734566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"DOI":"10.1186\/s12887-024-05298-6","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T20:43:14Z","timestamp":1734554594000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Management of severe pediatric Guillain-Barr\u00e9 syndrome in a\u00a0low-income country: efficacy and safety of therapeutic plasma exchange in pediatric patients: a retrospective study"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8103-8518","authenticated-orcid":false,"given":"Tahani","family":"Ali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0900-9381","authenticated-orcid":false,"given":"Faihaa","family":"Hkima Abou Fakher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6975-3535","authenticated-orcid":false,"given":"Malek","family":"Alawir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0344-4734","authenticated-orcid":false,"given":"Abdulsater","family":"Allababidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3617-0290","authenticated-orcid":false,"given":"Aya","family":"Sheikh Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,19]]},"reference":[{"issue":"5","key":"5298_CR1","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1038\/s41390-021-01919-3","volume":"92","author":"P Chaweekulrat","year":"2022","unstructured":"Chaweekulrat P, Sanmaneechai O. Prognostic model for time to achieve independent walking in children with Guillain-Barr\u00e9 syndrome. Pediatr Res. 2022;92(5):1417\u201322. https:\/\/doi.org\/10.1038\/s41390-021-01919-3.","journal-title":"Pediatr Res"},{"key":"5298_CR2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1159\/000505964","volume":"3","author":"S Al Hamdani","year":"2020","unstructured":"Al Hamdani S, Aljanabi F, Abdulrasool M, Salman A. Child with Guillain-Barr\u00e9 Syndrome Responding to Plasmapheresis: A Case Report. Case Rep Acute Med. 2020;3:4\u201311. https:\/\/doi.org\/10.1159\/000505964.","journal-title":"Case Rep Acute Med."},{"key":"5298_CR3","doi-asserted-by":"publisher","unstructured":"Elahi E, Ashfaq M, Nisa BU, Chachar S. Plasma Exchange Versus Intravenous Immunoglobulin in Children with Guillain Barr\u00e9 Syndrome. J Dow Univ Health Sci. 2019;13:133\u20137. https:\/\/doi.org\/10.36570\/JDUHS.2019.3.693.","DOI":"10.36570\/JDUHS.2019.3.693"},{"key":"5298_CR4","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1542\/PIR.33-4-164","volume":"33","author":"BA Rosen","year":"2012","unstructured":"Rosen BA. Guillain-Barr\u00e9 Syndrome. Pediatr Rev. 2012;33:164\u201371. https:\/\/doi.org\/10.1542\/PIR.33-4-164.","journal-title":"Pediatr Rev."},{"issue":"6","key":"5298_CR5","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1097\/00008480-199512000-00006","volume":"7","author":"RH Jones Jr","year":"1995","unstructured":"Jones RH Jr. Guillain-Barre syndrome in children. Curr Opin Pediatr. 1995;7(6):663\u20138. https:\/\/doi.org\/10.1097\/00008480-199512000-00006.","journal-title":"Curr Opin Pediatr."},{"key":"5298_CR6","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0140-6736(16)00339-1","volume":"388","author":"HJ Willison","year":"2016","unstructured":"Willison HJ, Jacobs BC, van Doorn PA. Guillain-Barr\u00e9 syndrome. Lancet. 2016;388:717\u201327. https:\/\/doi.org\/10.1016\/S0140-6736(16)00339-1.","journal-title":"Lancet."},{"key":"5298_CR7","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1055\/S-2007-981686","volume":"38","author":"R Korinthenberg","year":"2007","unstructured":"Korinthenberg R, Schessl J, Kirschner J. Clinical presentation and course of childhood Guillain-Barr\u00e9 syndrome: a prospective multicentre study. Neuropediatrics. 2007;38:10\u20137. https:\/\/doi.org\/10.1055\/S-2007-981686.","journal-title":"Neuropediatrics."},{"key":"5298_CR8","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/S0140-6736(78)92644-2","volume":"2","author":"RAC Hughes","year":"1978","unstructured":"Hughes RAC, Newsom-Davis JM, Perkin GD, Pierce JM. Controlled trial prednisolone in acute polyneuropathy. Lancet (London, England). 1978;2:750\u20133. https:\/\/doi.org\/10.1016\/S0140-6736(78)92644-2.","journal-title":"Lancet (London, England)."},{"key":"5298_CR9","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/J.NCL.2013.01.005","volume":"31","author":"MM Dimachkie","year":"2013","unstructured":"Dimachkie MM, Barohn RJ. Guillain-Barr\u00e9 syndrome and variants. Neurol Clin. 2013;31:491\u2013510. https:\/\/doi.org\/10.1016\/J.NCL.2013.01.005.","journal-title":"Neurol Clin."},{"key":"5298_CR10","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1002\/MUS.26831","volume":"61","author":"HA Beydoun","year":"2020","unstructured":"Beydoun HA, Beydoun MA, Hossain S, Zonderman AB, Eid SM. Nationwide study of therapeutic plasma exchange vs intravenous immunoglobulin in Guillain-Barr\u00e9 syndrome. Muscle Nerve. 2020;61:608\u201315. https:\/\/doi.org\/10.1002\/MUS.26831.","journal-title":"Muscle Nerve."},{"key":"5298_CR11","doi-asserted-by":"publisher","unstructured":"Bigi S, Banwell B, Yeh EA. Outcomes After Early Administration of Plasma Exchange in Pediatric Central Nervous System Inflammatory Demyelination. J Child Neurol. 2015;30(7):874\u201380. PMID: 25246301. https:\/\/doi.org\/10.1177\/0883073814545883.","DOI":"10.1177\/0883073814545883"},{"key":"5298_CR12","doi-asserted-by":"publisher","unstructured":"\u00d6zkale M, Erol I, \u00d6zkale Y, \u0130lknur Kozano\u011flu. Overview of therapeutic plasma exchange in pediatric neurology: a single-center experience. Acta Neurol Belg. 2018;118:451\u20138. https:\/\/doi.org\/10.1007\/S13760-018-0961-5.","DOI":"10.1007\/S13760-018-0961-5"},{"key":"5298_CR13","doi-asserted-by":"publisher","unstructured":"Bobati SS, Naik KR. Therapeutic Plasma Exchange - An Emerging Treatment Modality in Patients with Neurologic and Non-Neurologic Diseases. J Clin Diagn Res. 2017;11:EC35\u20137. https:\/\/doi.org\/10.7860\/JCDR\/2017\/27073.10480.","DOI":"10.7860\/JCDR\/2017\/27073.10480"},{"key":"5298_CR14","doi-asserted-by":"publisher","unstructured":"Chevret S, Hughes RAC, Annane D. Plasma exchange for Guillain-Barr\u00e9 syndrome. Cochrane Database Syst Rev. 2017;2017. https:\/\/doi.org\/10.1002\/14651858.CD001798.PUB3\/EPDF\/ABSTRACT.","DOI":"10.1002\/14651858.CD001798.PUB3\/EPDF\/ABSTRACT"},{"key":"5298_CR15","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/J.TRANSCI.2013.04.015","volume":"48","author":"E Kaya","year":"2013","unstructured":"Kaya E, Keklik M, \u015eencan M, Yilmaz M, Keskin A, Kiki I, et al. Therapeutic plasma exchange in patients with neurological diseases: multicenter retrospective analysis. Transf Apheres Sci: Off J World Apher Assoc: Off J Eur Soc Haemapheresis. 2013;48:349\u201352. https:\/\/doi.org\/10.1016\/J.TRANSCI.2013.04.015.","journal-title":"Transf Apheres Sci: Off J World Apher Assoc: Off J Eur Soc Haemapheresis."},{"key":"5298_CR16","doi-asserted-by":"publisher","unstructured":"Y\u00fccesan C, \u00d6nder Arslan, Arat M, Y\u00fccemen N, Ayyildiz E, Ilhan O, et\u00a0al. Therapeutic plasma exchange in the treatment of neuroimmunologic disorders: review of 50 cases. Transf Apheres Sci: Off J World Apher Assoc: Off J Eur Soc Haemapheresis. 2007;36:103\u20137. https:\/\/doi.org\/10.1016\/J.TRANSCI.2006.06.008.","DOI":"10.1016\/J.TRANSCI.2006.06.008"},{"key":"5298_CR17","doi-asserted-by":"publisher","unstructured":"Korach JM, Guillevin L, Petitpas D, Berger P, Chillet P. Apheresis registry in France: indications, techniques, and complications. French Registry Study Group. Ther Apher: Off J Int Soc Apher Jpn Soc Apher. 2000;4:207\u201310. https:\/\/doi.org\/10.1046\/J.1526-0968.2000.00201.X.","DOI":"10.1046\/J.1526-0968.2000.00201.X"},{"key":"5298_CR18","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4103\/0972-2327.144301","volume":"18","author":"V Gafoor","year":"2015","unstructured":"Gafoor V, Jose J, Saifudheen K, Musthafa M. Plasmapheresis in neurological disorders: experience from a tertiary care hospital in South India. Ann Indian Acad Neurol. 2015;18:15. https:\/\/doi.org\/10.4103\/0972-2327.144301.","journal-title":"Ann Indian Acad Neurol."},{"key":"5298_CR19","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","volume":"366","author":"RAC Hughes","year":"2005","unstructured":"Hughes RAC, Cornblath DR. Guillain-Barr\u00e9 syndrome. Lancet (London, England). 2005;366:1653\u201366. https:\/\/doi.org\/10.1016\/S0140-6736(05)67665-9.","journal-title":"Lancet (London, England)."},{"key":"5298_CR20","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.1212\/WNL.0000000000007719","volume":"93","author":"C Verboon","year":"2019","unstructured":"Verboon C, Doets AY, Galassi G, Davidson A, Waheed W, P\u00e9r\u00e9on Y, et al. Current treatment practice of Guillain-Barr\u00e9 syndrome. Neurology. 2019;93:e59\u201376. https:\/\/doi.org\/10.1212\/WNL.0000000000007719.","journal-title":"Neurology."},{"key":"5298_CR21","doi-asserted-by":"publisher","unstructured":"Connelly-Smith L, Alquist CR, Aqui NA, Hofmann JC, Klingel R, Onwuemene OA, et\u00a0al. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice - Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Ninth Special Issue. J Clin Apher. 2023;38:77\u2013278. https:\/\/doi.org\/10.1002\/JCA.22043.","DOI":"10.1002\/JCA.22043"},{"key":"5298_CR22","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1159\/000050777","volume":"46","author":"HC Diener","year":"2001","unstructured":"Diener HC, Haupt WF, Kloss TM, Rosenow F, Philipp T, Koeppen S, et al. A preliminary, randomized, multicenter study comparing intravenous immunoglobulin, plasma exchange, and immune adsorption in Guillain-Barr\u00e9 syndrome. Eur Neurol. 2001;46:107\u20139. https:\/\/doi.org\/10.1159\/000050777.","journal-title":"Eur Neurol."},{"key":"5298_CR23","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S0140-6736(96)09095-2","volume":"349","author":"RAC Hughes","year":"1997","unstructured":"Hughes RAC. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barre syndrome. Lancet. 1997;349:225\u201330. https:\/\/doi.org\/10.1016\/S0140-6736(96)09095-2.","journal-title":"Lancet."},{"key":"5298_CR24","doi-asserted-by":"publisher","unstructured":"van\u00a0der Mech\u00e9 FGA, Schmitz PIM. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barr\u00e9 syndrome. Dutch Guillain-Barr\u00e9 Study Group. N Engl J Med. 1992;326:1123\u20139. https:\/\/doi.org\/10.1056\/NEJM199204233261705.","DOI":"10.1056\/NEJM199204233261705"},{"key":"5298_CR25","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1212\/WNL.0B013E31824DE293","volume":"78","author":"HS Patwa","year":"2012","unstructured":"Patwa HS, Chaudhry V, Katzberg H, Rae-Grant AD, So YT. Evidence-based guideline: intravenous immunoglobulin in the treatment of neuromuscular disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2012;78:1009\u201315. https:\/\/doi.org\/10.1212\/WNL.0B013E31824DE293.","journal-title":"Neurology."},{"key":"5298_CR26","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/J.1442-200X.2009.02951.X","volume":"52","author":"YM Ma","year":"2010","unstructured":"Ma YM, Liu TKT, Wong V. Guillain-Barre syndrome in southern Chinese children: 32 year experience in Hong Kong. Pediatr Int: Off J Jpn Pediatr Soc. 2010;52:13\u20139. https:\/\/doi.org\/10.1111\/J.1442-200X.2009.02951.X.","journal-title":"Pediatr Int: Off J Jpn Pediatr Soc."},{"key":"5298_CR27","doi-asserted-by":"publisher","unstructured":"Hughes RAC, Swan AV, van Doorn PA. Intravenous immunoglobulin for Guillain-Barr\u00e9 syndrome. Cochrane Database Syst Rev. 2014;2014. https:\/\/doi.org\/10.1002\/14651858.CD002063.PUB6.","DOI":"10.1002\/14651858.CD002063.PUB6"},{"key":"5298_CR28","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1212\/WNL.38.10.1639","volume":"38","author":"RP Kleyweg","year":"1988","unstructured":"Kleyweg RP, van der Mech\u00e9 FGA, Meulstee J. Treatment of Guillain-Barr\u00e9 syndrome with high-dose gammaglobulin. Neurology. 1988;38:1639\u201341. https:\/\/doi.org\/10.1212\/WNL.38.10.1639.","journal-title":"Neurology."},{"key":"5298_CR29","doi-asserted-by":"publisher","unstructured":"Y\u0131ld\u0131r\u0131m M, \u00d6mer Bekta\u015f, Botan E, \u015eahin S, Gurbanov A, Teber S, et\u00a0al. Therapeutic plasma exchange in clinical pediatric neurology practice: Experience from a tertiary referral hospital. Clin Neurol Neurosurg. 2021;207. https:\/\/doi.org\/10.1016\/J.CLINEURO.2021.106823.","DOI":"10.1016\/J.CLINEURO.2021.106823"},{"key":"5298_CR30","doi-asserted-by":"publisher","first-page":"98","DOI":"10.4103\/0973-6247.165834","volume":"10","author":"M Gajjar","year":"2016","unstructured":"Gajjar M, Patel T, Bhatnagar N, Solanki M, Patel V, Soni S. Therapeutic plasma exchange in pediatric patients of Guillain-Barre syndrome: Experience from a Tertiary Care Centre. Asian J Transfus Sci. 2016;10:98\u2013100. https:\/\/doi.org\/10.4103\/0973-6247.165834.","journal-title":"Asian J Transfus Sci."},{"key":"5298_CR31","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1111\/J.1537-2995.2007.01405.X","volume":"47","author":"B Michon","year":"2007","unstructured":"Michon B, Moghrabi A, Winikoff R, Barrette S, Bernstein ML, Champagne J, et al. Complications of apheresis in children. Transfusion. 2007;47:1837\u201342. https:\/\/doi.org\/10.1111\/J.1537-2995.2007.01405.X.","journal-title":"Transfusion."},{"key":"5298_CR32","first-page":"224","volume":"51","author":"SB Nadler","year":"1962","unstructured":"Nadler SB, Hidalgo JU, Bloch T. Prediction of blood volume in normal human adults. Surgery. 1962;51:224\u201332.","journal-title":"Surgery."},{"issue":"8","key":"5298_CR33","doi-asserted-by":"publisher","first-page":"665","DOI":"10.2340\/16501977-0235","volume":"40","author":"T Paternostro-Sluga","year":"2008","unstructured":"Paternostro-Sluga T, Grim-Stieger M, Posch M, Schuhfried O, Vacariu G, Mittermaier C, et al. Reliability and validity of the Medical Research Council (MRC) scale and a modified scale for testing muscle strength in patients with radial palsy. J Rehabil Med. 2008;40(8):665\u201371. https:\/\/doi.org\/10.2340\/16501977-0235.","journal-title":"J Rehabil Med."},{"key":"5298_CR34","doi-asserted-by":"publisher","unstructured":"Saad K, Mohamad IL, Hamed MAA, Tawfeek MSK, Ahmed AE, Baseer KAA, et\u00a0al. A comparison between plasmapheresis and intravenous immunoglobulin in children with Guillain-Barre syndrome in Upper Egypt. Ther Adv Neurol Disord. 2016;9. https:\/\/doi.org\/10.1177\/1756285615610471.","DOI":"10.1177\/1756285615610471"},{"key":"5298_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/CC10305\/TABLES\/3","volume":"15","author":"MA El-Bayoumi","year":"2011","unstructured":"El-Bayoumi MA, El-Refaey AM, Abdelkader AM, El-Assmy MMA, Alwakeel AA, El-Tahan HM. Comparison of intravenous immunoglobulin and plasma exchange in treatment of mechanically ventilated children with Guillain Barr\u00e9 syndrome: A randomized study. Crit Care. 2011;15:1\u20136. https:\/\/doi.org\/10.1186\/CC10305\/TABLES\/3.","journal-title":"Crit Care."},{"key":"5298_CR36","doi-asserted-by":"publisher","unstructured":"Nandeesha SS, Kasagga A, Hawrami C, Ricci E, Hailu KT, Salib K, et\u00a0al. Treatment Efficacy of Plasmapheresis Versus Intravenous Immunoglobulin in Guillain-Barr\u00e9 Syndrome Management: A Systematic Review. Cureus. 2024;16. https:\/\/doi.org\/10.7759\/CUREUS.57066.","DOI":"10.7759\/CUREUS.57066"},{"key":"5298_CR37","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/J.PEDIATRNEUROL.2011.06.007","volume":"45","author":"J Tang","year":"2011","unstructured":"Tang J, Dai Y, Li M, Cheng M, Hong S, Jiang L, et al. Guillain-Barr\u00e9 syndrome in Chinese children: a retrospective analysis. Pediatr Neurol. 2011;45:233\u20137. https:\/\/doi.org\/10.1016\/J.PEDIATRNEUROL.2011.06.007.","journal-title":"Pediatr Neurol."},{"key":"5298_CR38","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/S1734-1140(10)70261-9","volume":"62","author":"AB Pithadia","year":"2010","unstructured":"Pithadia AB, Kakadia N. Guillain-Barr\u00e9 syndrome (GBS). Pharmacol Rep. 2010;62:220\u201332. https:\/\/doi.org\/10.1016\/S1734-1140(10)70261-9.","journal-title":"Pharmacol Rep."},{"key":"5298_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2377-7-22\/FIGURES\/2","volume":"7","author":"M Barzegar","year":"2007","unstructured":"Barzegar M, Dastgiri S, Karegarmaher MH, Varshochiani A. Epidemiology of childhood Guillan-Barre syndrome in the north west of Iran. BMC Neurol. 2007;7:1\u20135. https:\/\/doi.org\/10.1186\/1471-2377-7-22\/FIGURES\/2.","journal-title":"BMC Neurol."},{"key":"5298_CR40","doi-asserted-by":"publisher","unstructured":"Halawa EF, Ahmed D, Nada MAF. Guillain-Barr\u00e9 syndrome as a prominent cause of childhood acute flaccid paralysis in post polio eradication era in Egypt. Eur J Paediatr Neurol: Off J Eur Paediatr Neurol Soc. 2011;15:241\u20136. https:\/\/doi.org\/10.1016\/J.EJPN.2010.11.008.","DOI":"10.1016\/J.EJPN.2010.11.008"},{"key":"5298_CR41","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/ANA.410280112","volume":"28","author":"MA Epstein","year":"1990","unstructured":"Epstein MA, Sladky JT. The role of plasmapheresis in childhood Guillain-Barr\u00e9 syndrome. Ann Neurol. 1990;28:65\u20139. https:\/\/doi.org\/10.1002\/ANA.410280112.","journal-title":"Ann Neurol."},{"key":"5298_CR42","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1159\/000184748","volume":"32","author":"A McGrogan","year":"2009","unstructured":"McGrogan A, Madle GC, Seaman HE, Vries CSD. The epidemiology of Guillain-Barr\u00e9 syndrome worldwide. A systematic literature review Neuroepidemiology. 2009;32:150\u201363. https:\/\/doi.org\/10.1159\/000184748.","journal-title":"A systematic literature review. Neuroepidemiology."},{"key":"5298_CR43","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/S0887-8994(03)00403-X","volume":"30","author":"PL Hung","year":"2004","unstructured":"Hung PL, Chang WN, Huang LT, Huang SC, Chang YC, Chang CJ, et al. A clinical and electrophysiologic survey of childhood Guillain- Barr\u00e9 syndrome. Pediatr Neurol. 2004;30:86\u201391. https:\/\/doi.org\/10.1016\/S0887-8994(03)00403-X.","journal-title":"Pediatr Neurol."},{"key":"5298_CR44","doi-asserted-by":"publisher","first-page":"527","DOI":"10.4103\/NEUROINDIA.NI_907_15","volume":"65","author":"S Vikrant","year":"2017","unstructured":"Vikrant S, Thakur S, Sharma A, Gupta D, Sharma S. Safety and efficacy of therapeutic membrane plasmapheresis in the treatment of Guillain-Barr\u00e9 syndrome: A study from a tertiary care hospital from India. Neurol India. 2017;65:527. https:\/\/doi.org\/10.4103\/NEUROINDIA.NI_907_15.","journal-title":"Neurol India."},{"key":"5298_CR45","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/0887-8994(93)90004-V","volume":"9","author":"PW Jansen","year":"1993","unstructured":"Jansen PW, Perkin RM, Ashwal S. Guillain-Barr\u00e9 syndrome in childhood: natural course and efficacy of plasmapheresis. Pediatr Neurol. 1993;9:16\u201320. https:\/\/doi.org\/10.1016\/0887-8994(93)90004-V.","journal-title":"Pediatr Neurol."},{"key":"5298_CR46","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1136\/JNNP.64.1.74","volume":"64","author":"JH Rees","year":"1998","unstructured":"Rees JH, Thompson RD, Smeeton NC, Hughes RAC. Epidemiological study of Guillain-Barr\u00e9 syndrome in south east England. J Neurol Neurosurg Pychiatry. 1998;64:74\u20137. https:\/\/doi.org\/10.1136\/JNNP.64.1.74.","journal-title":"J Neurol Neurosurg Pychiatry."},{"issue":"5","key":"5298_CR47","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1002\/1531-8249(199911)46:5<701::AID-ANA4>3.0.CO;2-7","volume":"46","author":"G Paradiso","year":"1999","unstructured":"Paradiso G, Tripoli J, Galicchio S, Fejerman N. Epidemiological, clinical, and electrodiagnostic findings in childhood Guillain-Barr\u00e9 syndrome: a reappraisal. Ann Neurol: Off J Am Neurol Assoc Child Neurol Soc. 1999;46(5):701\u20137. https:\/\/doi.org\/10.1002\/1531-8249(199911)46:5<701::AID-ANA4>3.0.CO;2-7.","journal-title":"Ann Neurol: Off J Am Neurol Assoc Child Neurol Soc."},{"key":"5298_CR48","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/PR.2017.67","volume":"82","author":"M Barzegar","year":"2017","unstructured":"Barzegar M, Toopchizadeh V, Maher MHK, Sadeghi P, Jahanjoo F, Pishgahi A. Predictive factors for achieving independent walking in children with Guillain-Barre syndrome. Pediatr Res. 2017;82:333\u20139. https:\/\/doi.org\/10.1038\/PR.2017.67.","journal-title":"Pediatr Res."},{"key":"5298_CR49","doi-asserted-by":"publisher","unstructured":"Kleyweg RP, Mech\u00e9 FGAVD, Schmitz PIM. Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barr\u00e9 syndrome. Muscle Nerve. 1991;14:1103\u20139. https:\/\/doi.org\/10.1002\/MUS.880141111.","DOI":"10.1002\/MUS.880141111"},{"key":"5298_CR50","doi-asserted-by":"publisher","unstructured":"Fateen T, Sultana N, Sarwar M, Saqlain N. Complications of Therapeutic Plasma Exchange in pediatric patients: an experience at a tertiary care hospital. Pak J Med Sci. 2023;39:994. https:\/\/doi.org\/10.12669\/PJMS.39.4.7002.","DOI":"10.12669\/PJMS.39.4.7002"},{"key":"5298_CR51","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/DMCN.14150","volume":"61","author":"M Eyre","year":"2019","unstructured":"Eyre M, Hacohen Y, Lamb K, Absoud M, Agrawal S, Gadian J, et al. Utility and safety of plasma exchange in paediatric neuroimmune disorders. Dev Med Child Neurol. 2019;61:540\u20136. https:\/\/doi.org\/10.1111\/DMCN.14150.","journal-title":"Dev Med Child Neurol."},{"key":"5298_CR52","doi-asserted-by":"publisher","unstructured":"Korach JM, Berger P, Giraud C, Perff-Desman CL, Chillet P. Role of replacement fluids in the immediate complications of plasma exchange. French Registry Cooperative Group. Intensive Care Med. 1998;24:452\u20138. https:\/\/doi.org\/10.1007\/S001340050595.","DOI":"10.1007\/S001340050595"},{"key":"5298_CR53","doi-asserted-by":"publisher","unstructured":"Basic-Jukic N, Kes P, Glavas-Boras S, Brunetta B, Bubic-Filipi L, Puretic Z. Complications of therapeutic plasma exchange: experience with 4857 treatments. Ther Apher Dial: Off Peer-Rev J Int Soc Apher Jpn Soc Apher Jpn Soc Dial Ther. 2005;9:391\u20135. https:\/\/doi.org\/10.1111\/J.1744-9987.2005.00319.X.","DOI":"10.1111\/J.1744-9987.2005.00319.X"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-024-05298-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-024-05298-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-024-05298-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T21:02:18Z","timestamp":1734555738000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-024-05298-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,19]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5298"],"URL":"https:\/\/doi.org\/10.1186\/s12887-024-05298-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3892021\/v1","asserted-by":"object"}]},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,19]]},"assertion":[{"value":"23 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was waived by the local Ethics Committee of Children\u2019s Hospital of Damascus University in view of the retrospective nature of the study and all the procedures being performed were part of the routine care. Informed consent to participate in this study was obtained from the parents or the legal guardians of all the participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"818"}}